Rejuve Biotech

Every AI tool in longevity medicine has the same weakness.

You enter patient data. The system gives a score. Then the clinician asks: “Why?”

And the model simply can't answer.

That’s a major problem in medicine, where unexplained decisions create regulatory, legal, and clinical risk.

Hyperon, the architecture behind Rejuve Biotech, takes a different approach.

Instead of a black-box output, Hyperon reasons through data step by step. Every biomarker, evidence pathway, and recommendation remains traceable.

Something significant is about to happen for clinicians 🧬

We're partnering with @ALISHealth_AI, the clinical co-pilot for longevity, to build the full technology infrastructure behind their platform. And we're doing it with an AI architecture that has never been deployed in clinical medicine before.

ALIS is founded by two people whose names need no introduction in this field: Martin O'Dea (Longevity Summit Dublin) and Prof. Brian Kennedy (NUS Medicine). Their science, including the LinAge clock (with Jan Gruber), the Intervention Atlas, and the PC-based methodology, is at the forefront of biological age research.

Rejuve Biotech provides a reasoning engine architecturally different from LLMs. Data ingestion, intelligence engine, clinician dashboard, reporting, and the infrastructure to scale it to 10,000+ clinics and 1 million+ patients.

The core of what we're bringing is Hyperon, a neural-symbolic framework built towards AGI. Every clinical AI platform in this space today uses black-box models. They give clinicians a score. Hyperon gives them a reasoning chain. Every recommendation in ALIS is traceable to specific biomarkers, weighted by evidence quality, and auditable by the clinician who acts on it.

And it’s happening right now.

If you're running a longevity clinic and want to be among the first, the waitlist is now open: forms.fillout.com/t/c34hFme48eus

We're here at @cats_summit!

Stop by our booth to meet Mozi - our AI co-scientist that's accelerating the discovery of therapeutics and helps scientists in translational research.

We're here at @cats_summit!

Stop by our booth to meet Mozi - our AI co-scientist that's accelerating the discovery of therapeutics and helps scientists in translational research.

An exciting and high-energy week kicks off in San Francisco as @JPMorgan Healthcare Week brings together the industry’s most innovative companies.

We’re on the ground showcasing how neuro-symbolic AI can accelerate breakthroughs in translational medicine.